Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA Wegovy bundle, in the UK private market, means a package that combines your semaglutide pens, clinical prescription and often delivery into a single price for a set period, typically one, two or three months. No single format is universal: what's bundled varies between providers, and Wegovy remains a prescription-only medicine requiring clinical assessment before any supply. This page explains what to look for, what the process involves and how to make sense of what's included.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy (semaglutide) is a GLP-1 receptor agonist licensed in the UK for weight management in adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as high blood pressure, high cholesterol or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. None of that changes when you buy as part of a bundle: the first step is always a consultation, and the prescription must be issued by a qualified clinician who has reviewed your health history personally.
At nume, every consultation is read the same day by a GPhC-registered Independent Prescriber, not passed to software. Identity is confirmed through photo-ID verification, and weight is checked on a live video call. Transfer patients and anyone moving to a higher dose go through an evidence check first. That sequence exists because the medicine is prescription-only under the Human Medicines Regulations 2012, and nothing in a bundle arrangement changes that legal position. You can read about our clinical approach if you'd like more detail before starting.
A question our prescribers hear most weeks is whether a bundle means a fixed dose for the whole period. It does not. Wegovy's licensed titration schedule runs from 0.25mg through 0.5mg, 1.0mg, 1.7mg and up to the 2.4mg maintenance dose, with each step lasting roughly four weeks. The MHRA also approved a 7.2mg dose in January 2026, initially via three 2.4mg pens weekly, followed by a dedicated single-dose 7.2mg pen approved in April 2026 for adults with a BMI of 30 or above. A three-month bundle will therefore typically span three different strengths, not three pens of the same dose.
The three-month bundle is the most commonly asked-about format in the UK private market, and for good reason: it covers roughly the first three titration steps, which is when most people's bodies are still adjusting to the medicine. Nausea, loose stools and mild reflux are most noticeable early in treatment and usually settle as the weeks pass, per NHS guidance on semaglutide. Having the supply confirmed in advance removes one source of anxiety during that adjustment period.
Not every bundle is equivalent. Before committing, it is worth asking four specific questions: does the price include the prescription fee, or is that added at checkout? Is clinical aftercare and dose-review support included, or billed separately? Is next-day delivery included, or charged per dispatch? And is there a subscription tied to the arrangement that auto-renews?
For context on how UK private treatment is priced overall, the Wegovy price guide covers what the market typically looks like across providers and dose levels. At nume, one transparent price covers the consultation, prescription, medicine, free next-working-day tracked DPD delivery and 7-day aftercare support. There are no subscriptions and no auto-renewals: every repeat order is reviewed by a prescriber before dispatch. If you'd like to explore what a bundle looks like across the full titration journey, our bundle options set out exactly what each period includes.
Counterfeit GLP-1 pens are a real and documented risk in the UK market. The MHRA has warned publicly about fake semaglutide and tirzepatide pens sold online, with enforcement in 2025 resulting in the seizure of approximately 20 million doses worth around £45 million at street value. Fake pens have been found to contain insulin in some cases. The safe check is simple: any online pharmacy supplying Wegovy legally must be registered on the GPhC register. You can verify a pharmacy's registration at the GPhC register before placing any order. Sellers who offer these medicines without a prescription, or who promote significant discounts, are a red flag.
If you are ready to find out whether Wegovy is clinically suitable for you, the next step is straightforward. Our prescribers review consultations the same day and dispatch approved orders before the end of the working day on orders placed before noon. Check your eligibility and start your free consultation to see what treatment, and which format, fits your situation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.